Tissue Sodium in Autoimmune Disease

首次发布于 2015 年 8 月 17 日

Biomarkers in Autoimmune Disease of Nervous System

计划入组 50,000 人 · 首次发布于 2024 年 7 月 15 日

Predicting Medication Response for Autoimmune Disease

计划入组 200 人 · 首次发布于 2021 年 8 月 9 日

autoimmune disease program

Autoimmune disease(Galixir)

NIK inhibitors (autoimmune disease)

Autoimmune Technologies, LLC

United States

Aslan Pharmaceuticals

Singapore

Rare Disease Research, LLC

Cullinan Therapeutics Licenses BCMA-Targeted Bispecific T Cell Engager for Autoimmune Disease Development

RheumaGen Unveils Universal HLA Gene-Editing Approach for Autoimmune Disease Treatment

Allogene's ALLO-329 Receives FDA IND Clearance for Autoimmune Disease Trial